Primary Record
stavudine
- In stock
- 3,665 g
- Purity
- 98.2 %
- CAS
- 3056-17-5
Compound Identifiers & Properties
- CAS
- 3056-17-5
- PubChem CID
- 18283
- SMILES
- CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO
- Canonical SMILES
- Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O
Names & Synonyms
- stavudine
- sanilvudine
- Zerit
- Estavudina
- Stavudinum
- 3056-17-5
- Zerit Xr
- 2',3'-Didehydro-3'-deoxythymidine
- Zerut XR
- ddeThd
- Stavudine (d4T)
- ddeTyd
- Zent
- D 4T (nucleoside)
- null
- staduvine
- Stavudinum [INN-Latin]
- Estavudina [INN-Spanish]
- Stavudine (dt4)
- 3'-Deoxy-2'-thymidinene
- 2',3'-Anhydrothymidine
- Stavudine RS
- Stavudine CRS
- Zerit(TM)
- Sanilvudine (JAN)
- Thymidine, 2',3'-didehydro-3'-deoxy-
- BMY-27857
- Dideoxydidehydrothymidine
- LiON
- Zerit (TN)
- BO9LE4QFZF
- D-4T[nucleoside]
- Stavudine (Standard)
- Didehydrodeoxythymidine
- UNII-BO9LE4QFZF
- Stavudine (USAN/INN)
- Stavudine [USAN:BAN:INN]
- 2',3'-Didehydro-3'-deoxythimidine
- 3'-Deoxy-2',3'-didehydrothymidine
- BMY 27857
- D 4T
- Stavudine, Monosodium Salt
- CHEMBL991
- RefChem:57733
- STAVUDINE [INN]
- Stavudine [USAN:INN:BAN]
- DTXSID1023819
- STAVUDINE [MI]
- 2'-Thymidinene, 3'-deoxy-
- MFCD00132921
- AC1Q6BSH
- STAVUDINE [HSDB]
- STAVUDINE [USAN]
- Opera_ID_1281
- D-4T
- SANILVUDINE [JAN]
- Zidovudine EP Impurity A
- D4T & GM-CSF
- 3'-deoxythymidin-2'-ene
- D0Z8EX
- STAVUDINE [MART.]
- BMY27857
- HSDB 7338
- AC1L2BQ9
- cid_5155
- MLS000028546
- STAVUDINE [USP-RS]
- STAVUDINE [WHO-DD]
- STAVUDINE [WHO-IP]
- DTXCID803819
- XNKLLVCARDGLGL-JGVFFNPUSA-N
- 3''-deoxy-2''-thymidine
- C10H12N2O4
- Lopac0_000336
- SCHEMBL38661
- STAVUDINE [EMA EPAR]
- CHEBI:63581
- cid_18283
- MLS000759504
- MLS001055348
- MLS001077292
- MLS001424091
- MLS006011922
- BIDD:GT0082
- NSC-759897
- 2',3' Didehydro 3' deoxythymidine
- Stavudine - Bio-X trade mark
- Stavudine [USAN:USP:INN:BAN]
- 2',3'-Anhydrothymidine; d4T
- STAVUDINE [EP IMPURITY]
- STAVUDINE [ORANGE BOOK]
- 2 ,3 -Dideoxythymidiene
- d4T
- NSC 163661
- NSC-163661
- STAVUDINE [EP MONOGRAPH]
- Bristol-Myers Brand of Stavudine
- CTK8B1419
- D4TMBY-27857-3
- GTPL12678
- HY-B0116R
- 1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
- BRN 0618327
- STAVUDINE [USP MONOGRAPH]
- NSC163661
- STAVUDINUM [WHO-IP LATIN]
- C10H14N2O4
- GLXC-07997
- HMS2051O20
- HMS2234C10
- HMS3039O05
- HMS3259L21
- HMS3261C13
- HMS3428C07
- HMS3714N22
- Pharmakon1600-01502339
- STAVUDINE (D4T) [VANDF]
- STAVUDINE (DT4) [VANDF]
- ZINC137884
- 2',3'-Didehydro-2',3'-dideoxythmidine
- BCP02952
- CID18283
- DRG-0043
- HY-B0116
- Tox21_110886
- Tox21_201393
- Tox21_300583
- Tox21_500336
- ABP000995
- ANW-26914
- BBL033763
- BDBM50013111
- CID:18283
- EBC-07706
- NCGC00023212-07
- NP3509
- NSC759897
- Stavudine for system suitability CRS
- Stavudine(Zidovudine EP Impurity A)
- STK801888
- Zidovudine EP Impurity A; Stavudine
- 1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine
- SMR000058350
- 2',3'-Didehydro-3'-deoxy-thymidine
- AKOS005622554
- C10-H12-N2-O4
- Tox21_110886_1
- AC-5263
- AN-7246
- CCG-100902
- CS-1872
- DB00649
- KS-1115
- LP00336
- LS-1160
- NC00152
- NC00684
- ND07118
- RP07238
- SDCCGSBI-0050324.P002
- ZIDOVUDINE IMPURITY A [WHO-IP]
- Bristol-Myers Squibb Brand of Stavudine
- KS-00000H34
- 2'',3''-didehydro-3''-deoxythymidine
- 3''-deoxy-2'',3''-didehydrothymidine
- 3'-Deoxy-2',3'-didehydro-D-thymidine
- NCGC00023212-03
- NCGC00023212-04
- NCGC00023212-05
- NCGC00023212-08
- NCGC00023212-09
- NCGC00023212-10
- NCGC00023212-11
- NCGC00023212-12
- NCGC00023212-13
- NCGC00023212-14
- NCGC00023212-25
- NCGC00023212-30
- NCGC00254372-01
- NCGC00258944-01
- NCGC00261021-01
- Stavudine 100 microg/mL in Acetonitrile
- AJ-12338
- BC203877
- BD164571
- BR-77340
- CPD000058350
- CPD000673569
- H940
- J83.276F
- SAM001246729
- SAM002589948
- SC-03292
- SID:76715721
- SMR000673569
- SY057970
- ZB004848
- 2',3'-didehydro-2',3'-dideoxythymidine
- 2',3'-dideoxy-2',3'-didehydrothymidine
- CAS-3056-17-5
- D 1413
- AB0013374
- AB1009564
- Thymidine, 2',3'-didehydro-, 3'-deoxy-
- ZIDOVUDINE IMPURITY A [EP IMPURITY]
- D3580
- EU-0100336
- NS00002353
- 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione
- 2',3'-DIDEHYDRO-3'-DEOXYTHYMIDINE (DDI)
- STV
- 1-(2,3-Dideoxy-beta-D-glycero-2-pentenofuranosyl)thymine
- 2'',3''-dideoxy-2'',3''-didehydrothymidine
- C07312
- D00445
- EN300-120634
- J10003
- S-2155
- AB00383018_18
- 056S175
- 1-(2,3-dideoxy-beta-glycero-pent-2-enofuranosyl)thymine
- A820433
- D018119
- F404709
- Q423984
- SR-01000075802
- 1-[(2R,5S)-5-(HYDROXYMETHYL)-2,5-DIHYDROFURAN-2-YL]-5-METHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE
- SR-01000075802-1
- SR-01000075802-4
- 1-(2,3-Dideoxy-.beta.-D-glycero-pent-2-enofuranosyl)thymine
- 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione
- 2 ,3 -Didehydro-2 ,3 -dideoxythymidine
- 2',3'-Didehydro-3'-deoxythymidine, >=98% (TLC)
- BRD-K93880783-001-26-6
- Z1530425068
- 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
- Stavudine, European Pharmacopoeia (EP) Reference Standard
- 1-[(2R,5S)-5-(Hydroxymethyl)-2,5-dihydrofuran-2-yl]thymine
- 1-[2,5-Dihydro-5beta-(hydroxymethyl)furan-2beta-yl]thymine
- 1-[5beta-(Hydroxymethyl)-2,5-dihydrofuran-2beta-yl]thymine
- Stavudine, United States Pharmacopeia (USP) Reference Standard
- Thymine, 1-(2,3-dideoxy-beta-D-glycero-pent-2-enofuranosyl)-
- Thymine, 1-(2,3-dideoxy-beta-D-glycero-pent-2-enofuranosyl)-(7CI,8CI)
- 1-((2R,5S)-5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione
- 1-(cis-5-(Hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
- Thymine, 1-(2,3-dideoxy-.beta.-D-glycero-pent-2-enofuranosyl)-
- 1-[5-(hydroxymethyl)-2,5-dihydro-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione & Colony-stimulating factor 2
- 220020-60-0
- Thymine, 1-(2,3-dideoxy-beta-D-glycero-pent-2-enofuranosyl)- (7CI,8CI)
- 1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4-dione
- 1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione
- 1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (ddeThd)
- 1-[(2R,5S)-2,5-Dihydro-5-(hydroxymethyl)-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione
- 3'- Azido-3'-deoxythymidine & Granulocyte-macrophage colony-stimulating factor
- 3'-Azido-3'-deoxythymidine & Granulocyte-macrophage colony-stimulating factor
- Stavudine for system suitability, European Pharmacopoeia (EP) Reference Standard
- 1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
- 1-[5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
- 2 inverted exclamation marka,3 inverted exclamation marka-Didehydro-3 inverted exclamation marka-deoxythymidine
- 2',3'-Didehydro-3'-deoxythmidine, 98%, a nucleoside analog that inhibits reverse transcriptase - 1G 1g
- DHT
- DTH
- Stavudine; 1-[(2R,5S)-5-(Hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione; Zidovudine Imp. A (EP); 3'-Deoxy-2'-thymidinene; 2',3'-Didehydro-3'-deoxythymidine; 3'-Deoxy-2',3'-didehydrothymidine; Avostav; BMY 27857; D 4T (nucleoside); NSC 163661; Sanilvudine; Staduvine; Stag; Stavir; Virostav; Zerit; d4T; 1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine; Ph Eur Zidovudine Impurity A; GR 92955X; Zidovudine Impurity A